Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
Vascular abnormality is a hallmark of most solid tumors and facilitates immune evasion. Targeting the abnormal metabolism of tumor endothelial cells (TECs) may provide an opportunity to improve the outcome of immunotherapy. Here, in comparison to vascular endothelial cells from adjacent peritumoral...
Saved in:
Main Authors: | Yunlong Shan (Author), Qi Ni (Author), Qixiang Zhang (Author), Mengying Zhang (Author), Bin Wei (Author), Lingge Cheng (Author), Chongjin Zhong (Author), Xinyu Wang (Author), Qingqing Wang (Author), Jiali Liu (Author), Jingwei Zhang (Author), Jingjing Wu (Author), Guangji Wang (Author), Fang Zhou (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics
by: Chongjin Zhong, et al.
Published: (2020) -
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
by: Yanyan Xu, et al.
Published: (2022) -
Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy
by: Hongyan Zhang, et al.
Published: (2023) -
Immunotherapy, Tumor Microenvironment and Survival Signaling
Published: (2022) -
Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy
by: Youhan Liu, et al.
Published: (2023)